Moleculin Biotech (MBRX) Q2 2024 Earnings

10MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-5.09
-3.46
-1.82
-0.19

Details

Expected EPS
-3.53
Actual EPS
-2.02
Surprise EPS
1.51
Surprise Percent
+42.78%

Description

Moleculin Biotech (MBRX) has reported earnings of -2.02 per share for Q2 2024.

0 Comments

Share your thoughts